Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2024BMJOpen Access

3PC-021 Formulation of voriconazole ovules and efficacy in vulvovaginal Ccandidiasis by candida glabrata: a case report

View Full Paper
Ask AI
Bookmark
Share

Authors

AGA López GómezLFLupe Rodríguez-de FranciscoCCC Carrascal-Mozo

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gómez et al. (2024) studied this question.

synapsesocial.com/papers/68e76a16b6db6435876df2f8https://doi.org/10.1136/ejhpharm-2024-eahp.78
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Voriconazole Loaded Spanlastics: Design, Formulation, Optimization, and Randomized Controlled Clinical Insights for Vulvovaginal Candidiasis Therapy2025 · 16 citations
  2. 2Ointment for Topical Ocular Delivery of Voriconazole: Formulation Development, In‐Vitro Characterization & In‐Vivo Pharmacokinetic Assessment2026 · 2 citations
  3. 3Therapeutic Tools for Vulvovaginal Candidiasis: Current and Emerging Antifungal Agents2026 · 4 citations
  4. 4Preparation and Evaluation of Voriconazole as Topical Organogel2025
  5. 5Phase III Study to Evaluate the Efficacy and Safety of Two Novel Fixed-Dose Vaginal Ovule Formulations in the Treatment of Various Vaginal Infections: One-Shot Study Running Title: Phase III study of two novel vaginal ovules2024